{"id":"control-arm-seq","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL1643772","moleculeType":"Small molecule","molecularWeight":"494.57"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"In clinical trial terminology, a 'control arm' represents the comparator group in a study, which may receive standard of care, placebo, or an active comparator. 'SEQ' likely indicates a sequential or crossover design element. Without specification of what the control arm actually contains, no mechanistic description of an active drug can be provided.","oneSentence":"This is a control arm designation for a sequential (SEQ) study design, not an active pharmaceutical agent.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:45:24.402Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Control arm (SEQ):","genericName":"Control arm (SEQ):","companyName":"University College, London","companyId":"university-college-london","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}